Measuring Swelling Around Treated Brain Tumors May Reveal Why Some Fail Radiation Therapy

When a brain metastasis refuses to shrink after stereotactic radiosurgery, neurosurgeons face one of the most consequential diagnostic dilemmas in modern neuro-oncology: is the lesion a recurrent tumor that demands systemic therapy escalation, or is it radiation necrosis, a benign but sometimes symptomatic inflammatory reaction to the treatment itself? The distinction dictates entirely different management pathways, yet on conventional magnetic resonance imaging the two entities can look remarkably alike. A new study from Yale University School of Medicine and collaborating institutions, published in the Journal of Neuro-Oncology, suggests that the answer may lie not in the enhancing tumor core that radiologists traditionally measure, but in the swelling that surrounds it. By tracking volumetric changes in FLAIR hyperintensity, the bright signal on fluid-attenuated inversion recovery sequences that marks edema and infiltrative disease, the researchers found that the trajectory of perilesional edema in the first weeks after Gamma Knife radiosurgery carries meaningful information about what pathology will later reveal at surgery.

The retrospective analysis drew on an institutional database of patients who had received first-time stereotactic radiosurgery for a single brain metastasis and subsequently underwent surgical resection of that same lesion, providing the gold standard of histopathological confirmation for what the imaging had shown. Thirty-six patients met the inclusion criteria. For each patient, the team manually measured tumor volumes before treatment and at three standardized post-treatment intervals: six weeks, three months, and six months. Rather than relying on a single measurement dimension, the investigators segmented three distinct tissue compartments on each scan: the contrast-enhancing volume, the FLAIR hyperintense volume, and the necrotic component. From these they derived two ratios intended to capture the relationship between edema and tumor burden, the FLAIR-to-enhancing ratio and the enhancing-to-necrotic ratio, and then modeled how each parameter evolved over time.

The volumetric data revealed a treatment effect that was real but incomplete. Mean enhancing volume declined by 28.5 percent from baseline at six weeks, 25.8 percent at three months, and 18.9 percent at six months, a pattern consistent with an initial radiosurgical response that partially attenuated over the follow-up window. The FLAIR volume followed a different and more revealing course: it fell by 16.9 percent at six weeks and 22.2 percent at three months, but then rebounded to nearly baseline, changing only 2.4 percent from the pretreatment measurement at six months. This divergence between the enhancing core and the surrounding hyperintensity is precisely why the authors argue that single-compartment assessment, the standard practice in most surveillance protocols, misses a substantial portion of the biological story unfolding after radiation.

Statistical analysis confirmed that the two compartments do not move independently. Percent changes in FLAIR volume and enhancing volume correlated significantly at both the six-week time point, with a p-value of 0.004, and the three-month time point, where the association was even stronger at p less than 0.001. In practical terms, lesions whose enhancing cores were shrinking tended to show shrinking edema as well, at least in the early post-treatment period. But the correlation broke down in the cohort’s most clinically important subgroup: the patients whose lesions ultimately failed treatment and required resection. When the investigators stratified the surgical outcomes by pathology, the FLAIR-to-enhancing ratio trended differently between radiation necrosis and recurrent tumor, and patients who developed radiation necrosis had significantly lower FLAIR volumes at six weeks compared with those whose lesions harbored recurrent tumor.

This finding carries a counterintuitive implication. Clinicians often assume that more edema signals more trouble, and in the context of symptomatic mass effect that intuition holds. But the data suggest the opposite relationship for diagnostic purposes: a lesion that retains relatively little FLAIR hyperintensity six weeks after radiosurgery, despite failing to shrink, is more likely to be radiation necrosis, whereas a non-responding lesion wrapped in substantial and persistent edema raises greater concern for viable, actively growing tumor. The biological rationale is plausible. Radiation necrosis is fundamentally a vascular and inflammatory process driven by endothelial injury, blood-brain barrier disruption, and cytokine-mediated swelling, whereas recurrent tumor generates edema through tumor-cell infiltration, angiogenic signaling, and active secretion of vascular permeability factors. The two processes stamp different volumetric signatures on the surrounding brain, and the early post-treatment window appears to be when those signatures are most distinguishable.

Beyond the diagnostic ratios, the study identified which patient and lesion characteristics shape the edema trajectory itself. Linear mixed-effects models, a statistical framework well suited to repeated measurements nested within individual patients, showed that baseline lesion size, baseline FLAIR volume, and the FLAIR-to-enhancing ratio all influenced FLAIR trajectories with p-values below 0.001. Primary cancer type and sex also emerged as significant factors, each with p-values of 0.02. These results echo a growing body of literature indicating that peritumoral edema after radiosurgery is not a uniform phenomenon but one modulated by tumor histology, systemic therapy exposure, and intrinsic lesion characteristics. Larger lesions and those with greater baseline edema burdens follow different swelling curves than small, dry lesions, which means that any future edema-based diagnostic criterion will likely need to be normalized to baseline values rather than applied as an absolute threshold.

The clinical context makes the stakes of this work concrete. Stereotactic radiosurgery has become a cornerstone of brain metastasis management precisely because it delivers ablative doses of radiation with submillimeter accuracy while sparing surrounding tissue, allowing many patients to avoid whole-brain radiation and its cognitive sequelae. But local failure rates remain nontrivial, and a meaningful fraction of patients with non-responding lesions eventually come to surgery. Prior biopsy series have shown that enlarging lesions after radiosurgery frequently turn out to be radiation necrosis rather than tumor, which means that a substantial number of patients may currently undergo resection, or receive escalating systemic therapy, for a process that was never malignant. Conversely, misattributing recurrent tumor to necrosis delays effective treatment in a population where every month of uncontrolled intracranial disease matters. Any imaging tool that sharpens this fork in the road has immediate utility.

The Yale team’s methodological choices deserve attention because they point toward how such a tool could be deployed at scale. Manual segmentation of FLAIR hyperintensity is labor-intensive and subject to interobserver variability, which has historically limited edema volumetry to research settings. The authors explicitly recommend that automated edema volumetry be incorporated into routine post-SRS surveillance, and their proposal aligns with recent pilot work demonstrating that picture archiving and communication system-integrated volumetric tools can provide peritumoral edema measurements that add information beyond standard response assessment criteria for brain metastases. If FLAIR volume trajectories can be generated automatically at each surveillance scan, the six-week and three-month ratios identified in this study could become practical decision-support metrics, flagging non-responding lesions whose edema behavior suggests recurrent tumor for earlier tissue diagnosis or intensified imaging follow-up with advanced sequences such as perfusion and diffusion MRI.

The study’s limitations are those inherent to its design. Thirty-six patients from a single institution, all of whom underwent surgery and therefore represent the more severe end of the non-response spectrum, is a modest and selected sample. The pathological endpoint was available only for lesions that failed treatment, so the volumetric signatures of well-behaved responding lesions could not be compared against a full spectrum of outcomes. The authors also note that edema trajectories are variable across patients, and the FLAIR-to-enhancing ratio trended, rather than decisively separated, the two pathological groups at all time points, with the significant six-week FLAIR volume difference being the clearest single discriminator. Validation in larger, multi-institutional cohorts, ideally with prospective edema volumetry and standardized imaging protocols, will be essential before these thresholds inform treatment decisions.

Even so, the study adds a deceptively simple idea to the post-radiosurgery toolkit: the brain around the tumor is talking, and clinicians should start listening to it quantitatively. For two decades, surveillance after radiosurgery has centered on the enhancing lesion, with edema assessed qualitatively, if at all. This analysis demonstrates that perilesional FLAIR volume follows measurable, statistically characterizable trajectories that correlate with the enhancing compartment early after treatment and diverge in diagnostically informative ways when treatment fails. As automated segmentation matures and is folded into routine radiology workflows, the humble edema measurement that radiologists have long eyeballed as background noise may become one of the most actionable numbers on the post-radiosurgery scan, helping to spare patients with radiation necrosis from unnecessary surgery while accelerating definitive intervention for those whose tumors have truly returned.

Subject of Research: Volumetric MRI analysis of edema and enhancement changes after stereotactic radiosurgery for non-responding brain metastases

Article Title: Volumetric analysis of radiographic changes after stereotactic radiosurgery for treatment of non-responding brain metastases

Article References: Rajkumar, S., Moy, H., Ji, X., Aboian, M., & Chiang, V. (2026). Volumetric analysis of radiographic changes after stereotactic radiosurgery for treatment of non-responding brain metastases. Journal of Neuro-Oncology, 180(1), Article 7. https://doi.org/10.1007/s11060-026-05824-9

Image Credits: AI Generated

DOI: 10.1007/s11060-026-05824-9

Keywords: stereotactic radiosurgery, brain metastases, radiation necrosis, FLAIR volumetry, perilesional edema, Gamma Knife, MRI surveillance, tumor recurrence, neuro-oncology, volumetric analysis, Journal of Neuro-Oncology, Volumetric